Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Tarsus Pharmaceuticals (TARS) Long-Term Debt Issuances (2022 - 2024)

Historic Long-Term Debt Issuances for Tarsus Pharmaceuticals (TARS) over the last 3 years, with Q2 2024 value amounting to $75.0 million.

  • Tarsus Pharmaceuticals' Long-Term Debt Issuances changed N/A to $75.0 million in Q2 2024 from the same period last year, while for Sep 2025 it was $75.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $75.0 million for FY2024, which is 65000.0% up from last year.
  • Per Tarsus Pharmaceuticals' latest filing, its Long-Term Debt Issuances stood at $75.0 million for Q2 2024.
  • Tarsus Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $75.0 million during Q2 2024, with a 5-year trough of $5.0 million in Q1 2023.
  • For the 3-year period, Tarsus Pharmaceuticals' Long-Term Debt Issuances averaged around $26.2 million, with its median value being $12.5 million (2022).
  • Examining YoY changes over the last 5 years, Tarsus Pharmaceuticals' Long-Term Debt Issuances showed a top increase of 7500.0% in 2023 and a maximum decrease of 7500.0% in 2023.
  • Tarsus Pharmaceuticals' Long-Term Debt Issuances (Quarter) stood at $20.0 million in 2022, then crashed by 75.0% to $5.0 million in 2023, then surged by 1400.0% to $75.0 million in 2024.
  • Its Long-Term Debt Issuances stands at $75.0 million for Q2 2024, versus $5.0 million for Q3 2023 and $5.0 million for Q1 2023.